seneciphylline

Subscribe to Selected New Research on seneciphylline

2 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: RN given refers to parent cpd; structure

Also Known As:

seneciphylline, (12 beta,15E)-isomer; 13,19-didehydro-12-hydroxysenecionan-11,16-dione

Bio-Agent Context: Research Results

Heterocyclic Compounds: 23

Alkaloids: 637

Pyrrolizidine Alkaloids: 61

seneciphylline: 2

2-Ring Heterocyclic Compounds

Pyrrolizidine Alkaloids: 61

seneciphylline: 2

Related Diseases

1.	Pulmonary Heart Disease (Cor Pulmonale) 04/15/1977 - "Hypertrophy of pulmonary arteries and arterioles with cor pulmonale in rats induced by seneciphylline, a pyrrolizidine alkaloid." Order ALL the reference details at left...
2.	Neoplasms (Cancer) 01/01/2008 - "Among the PAs definitively identified, senecionine, seneciphylline, and senkirkine are known tumorigens capable of inducing liver tumors in experimental animals, while seneciphylline N-oxide and senecionine N-oxide are probably tumorigenic due to their potential conversion into seneciphylline and senecionine via metabolic reduction in the body" Order ALL the reference details at left...
3.	Hypertrophy 04/15/1977 - "Hypertrophy of pulmonary arteries and arterioles with cor pulmonale in rats induced by seneciphylline, a pyrrolizidine alkaloid." Order ALL the reference details at left...

Related Drugs and Biologics

1.	p-Aminosalicylic Acid (PAS)
2.	senecionine N-oxide
3.	senkirkine
4.	senecionine (integerrimine)

Best Treatments:
Research Summary Report
on Pulmonary Heart Disease

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 37 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>